NEW YORK, Feb. 24, 2015 /PRNewswire/ — This report analyzes the worldwide markets for Marine Biotechnology in US$ Million. The Global market is further analyzed by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The Major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 84 companies including many key and niche players such as -Aker BioMarine ASAqua Bio Technology ASABASF SECP KelcoCyanotech Corp.Read the full report: http://www.reportlinker.com/p080467-summary/view-report.htmlI. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3By Product Segment I-3Biomaterials I-3Bioactive Substances I-3Others I-3By End-Use Application I-4Industrial Products I-4Health Care/Biotechnology I-4Consumer Products I-4Public Services and Infrastructure I-4Others I-4II. EXECUTIVE SUMMARY1. INDUSTRY OVERVIEW II-1A Quick Primer II-1Marine Biotechnology: A Science to Address Global Challenges II-2Current and Future Analysis II-3Impact of Economic Uncertainty in Retrospect II-4Noteworthy Trends & Issues II-5Medical, Food and Cosmetic Sectors Garner Research Dollars II-5Select Marine Bio-Products Commercially Available II-5Health-Promoting Benefits of Marine Algal Proteins II-5Sea Anemone Toxins: Opportunities for Pharma & AgriculturalSectors II-6Marine Worm: Potential Role in Medical Applications II-6Coral Reefs Offer Abundant Opportunities II-7Marine Microalgae: Promising Potential in Varied Industries II-7Commercially Cultivated Marine Microalgae Species and theirApplications II-8Major Applications of Marine Microalgae Biomass or theirExtracts II-8Polysaccharides from Marine Microalgae Holds TremendousPotential II-9Select Marine Microalgae Species Producing Polysaccharides II-9Carotenoids of Marine Origin: Key Applications II-10Major Commercially Available Carotenoids II-10Rising Demand for HVAB’s: Threat to Marine Biodiversity? II-11Marine Ingredients for Bonding Applications: A Research Focus II-11Biopharmaceutical Companies Shift towards Marine NaturalProducts II-11Technology Advancements Aid Research Activities II-12Partnerships: Vital for Development of Marine BiotechnologyResearch II-12Megaprojects Hold Significance for Marine BiotechnologyDevelopment II-14Lack of R&D Investment in Marine Biotech: A Challenge II-14Preserving Marine Ecology: A Prime Concern II-152. A REVIEW OF END-USE MARKETS/ APPLICATIONS II-16Marine Biotechnology for Sustainable Production of HealthyFood Products II-16Table 1: World Population by Geographic Region (2000-2050)(in Millions) (includes corresponding Graph/Chart) II-17Table 2: Top 5 Seafood Consuming Nations Based on Per-CapitaIntake (2013) (includes corresponding Graph/Chart) II-18Table 3: World Aquaculture Market (2012): Breakdown ofProduction Volume by Region (in ‘000 Tonnes) (includescorresponding Graph/Chart) II-18Table 4: World Capture Fisheries and Aquaculture Market(2013): Percentage Breakdown of Production Volume by Inlandand Marine Segments (includes corresponding Graph/Chart) II-19Table 5: Global Aquaculture Market (2013): Percentage ShareBreakdown of Production Volume by Fish Type (includescorresponding Graph/Chart) II-19Marine Resources as Functional Food Ingredients II-21Health Benefits of Few Marine-derived Functional FoodIngredients II-22Marine-Derived Nutraceuticals II-23Major Marine Nutraceutical Products: A Glance II-23Global Omega-3 Ingredients Market – A Review II-24Table 6: World Omega-3 Dietary Supplements Market (2013):Percentage Share Breakdown of Volume Sales by GeographicRegion – North America, Europe, Asia-Pacific, and Rest ofWorld (includes corresponding Graph/Chart) II-25Marine Biotechnology for Energy Supply II-25Feasibility of Using Algae for Biofuel Production II-26Application of Marine Organisms in the Cosmetics Industry II-26Marine Ingredients in Cosmetics Industry II-27Focus Shifts to Sustainable Sourcing of Marine Ingredients inCosmetics Industry II-27Marine Biotechnology for Industrial Processing II-28Marine Microbial Enzymes II-29Marine-Derived Biopolymers & Biomaterials II-30Marine Micro & Macro Algae II-30Chitin & Chitosan II-31Marine Bacteria II-32Bioceramics II-32Extremozymes II-32Marine Biotechnology for Protecting Marine Ecosystems II-33Biofouling II-33Detecting Marine Pathogenic Organisms II-33Bioremediation of Marine Ecosystems II-34Marine Coatings Market II-34Marine-Derived Pharmaceuticals II-34Brief History II-34Major Marine Sources for Drugs II-35Applications of Marine Products in Pharmaceutical Industry II-35Invertebrates – Major Focus of Research II-36Marine Flora – Largely Unexplored II-36Research Focus Entrenched on Marine Drugs II-37Marine Pharmaceutical Products – Development/Approval Status(2014) II-38Robust Clinical Pipeline to Support Growth II-39Anti-Cancer Drugs Dominate Drug Development Pipeline II-40Overview of Approved Anti-Tumor Drugs of Marine Origin II-40PharmaMar: Undisputed Leader in Oncology Medicines of MarineOrigin II-41Cardiovascular Marine Products II-41Cardiovascular Marine Products by Marine Source II-41An Overview of Select Cardiovascular Marine Products II-42Key Challenges in Discovery of Marine-derived Drugs II-42Marine Genetic Resources: Regulatory Framework II-43The Convention on Biological Diversity (CBD) and the NagoyaProtocol II-43The United Nations Convention on the Law of the Sea II-443. R&D ACTIVITY IN MARINE BIOTECHNOLOGY – A REVIEW II-45Overview II-45R&D Initiatives, Funding Programs & Research Priorities forMarine Biotechnology II-46The United States II-46Canada II-47Japan II-47Europe II-47Turkey II-48Asia II-48Australia & New Zealand II-48China II-49India II-49South Korea II-49Southeast Asia II-49Latin America II-50Middle East & Africa II-50International Efforts in Marine Biotechnology Research II-50Major R&D Projects in Marine Biotechnology Space II-51EU Embarks on Ground-Breaking Marine Plankton Project II-51KIOST Augments Research on Marine Biotechnology II-51EU Launches BlueGenics Research Project II-51Smithsonian Tropical Research Institute to Launch GlobalMarine Biodiversity Project II-524. MARINE BIOTECHNOLOGY – AN OVERVIEW II-53Prelude II-53Significance of Marine Biodiversity II-53Marine Biotechnology: Definition II-54Why are Marine Organisms Crucial? II-54Sources of Marine Biotech Products II-55Key Marine Sources and Products II-55Select Marine-Derived Products II-56Marine Sponges II-56Marine Plants II-56Protista II-56Marine Bacteria II-57Marine Fungi II-57Types of Marine Biotech Products II-57Marine Biomaterials II-57Marine Adhesives II-57Marine Bioactive Substances II-58Enzymes II-58Haloperoxidase Enzymes II-58Thermostable DNA-Modifying Enzymes II-58Other Marine Products and Processes II-59Marine Biomass II-59Marine Bio-Process II-59Significant Bio-Processes and their Applications II-59End-Use Analysis II-59Foods II-60Nutraceuticals II-61Medicine II-61Cosmetics II-61Research Tools II-61Processing Technologies II-62New Energy Sources II-62Agriculture II-62Industrial II-62Food Safety II-63Environmental Management II-63Bioremediation II-63Marine Biosurfactants II-63Select Biosurfactants Produced from Marine Microorganisms II-64Aquaculture and Marine Biotechnology II-64Industrial Applications II-64Healthcare II-65Select Marine Diterpenes and Their Biological Activity II-65Bioprospecting II-66Consumer Products II-66Select Macroalgal Materials and Applications in CosmeticIndustry II-67Public Services and Infrastructure II-67Others II-67An Insight into Select Marine-Origin Products II-67Agar II-67Major Seaweeds Used for Extracting Agar and Agarose II-68Alginate II-68Astaxanthin II-69Carrageenan II-69Chitin and Chitosan II-70Chitin II-70Chitosan II-70Select Industrial Applications of Chitosan II-70Collagen II-71Salmon Calcitonin II-715. KEY RESEARCH FINDINGS ON MARINE ORGANISMS II-72New Research Finding Reveals the Role of Opisthobranchs inLignarenones Biosynthesis II-72Norwegian Researchers Explore Potential of Tunicate as aSource of Biofuel and Fish Feed II-72Scientists Unearth Medicinal Properties of Marine Enzyme,Bacillus Licheniformis II-73Salmon Peptone for Producing High-Value Biotech Products II-73Norwegian Researchers Study Potential of Farmed Salmon Wasteas Nutrients to Nourish Kelp and Mussel II-73Researchers Study Effectiveness of Alginate Supplementation onWeight Loss II-73Lamellarins Can Stop Cancer Drug Resistance: New Finding onMarine Natural Product II-74Evaluation of DHA and EPA Concentration in Algal Species II-74Study of Potential Applications of Delesseria Sanguinea II-75Scientists Use Bacteria Occurring in Marine Waters to DevelopNew Assays II-756. PRODUCT INTRODUCTIONS/INNOVATIONS II-76BiotechMarine Develops Sea Shine II-76Lipotec Launches Seacode™ II-76Bluewave Marine Ingredients Launches AminoMarine™ Fish ProteinPowder II-76Cyvex Nutrition Rolls Out Protomine™ Fish Protein Powder II-76Lipotec Unveils Seacode Marine-based Anti-Ageing Ingredient II-76Marie Veronique Organics Rolls Out Pacific Line of Anti-AgingProducts II-76DSM Unveils DHA plus EPA™ Product II-76Aqua Bio Technology Launches New Marine-Based Ingredients II-77La Prairie Launches Lifestyle Collection II-777. RECENT INDUSTRY ACTIVITY II-78Superba™ Krill Oil Receives Regulatory Approval in India II-78GlycoMar Collaborates With Biopol II-78Aker Biomarine Inks Licensing Agreement with Neptune II-78Aker BioMarine Inks Distribution Agreement with BioMar II-78HEMARINA Inks Deal with LFB Bio-Manufacturing II-78Lallemand Takes Over Aquapharm II-78BASF Acquires Pronova II-79FMC Takes Over Epax II-79Seppic Takes Over BiotechMarine II-79Aqua Bio Technology Bags Contracts from Cosmetics Company II-79CRBM and CNBE Ink Marine Biotechnology Agreement II-79Olympic Seafood Enters into Long-Term Licensing Agreement withAker BioMarine II-79Stemtech International Inks Agreement with Marinova II-79ABT Bags Multi Million Contract from Restorsea forAquabeautine XL™ Ingredient II-79Aquapharm Collaborates with c-LEcta II-80Aqua Bio Technology Signs Agreement with Amway II-80Aquapharm Enters into Partnership with Aqua Bio Technology II-808. FOCUS ON SELECT PLAYERS II-81Aker BioMarine AS ( Norway) II-81Aqua Bio Technology ASA ( Norway) II-81BASF SE ( Germany) II-81CP Kelco (US) II-82Cyanotech Corp. (US) II-82Nutrex Hawaii (US) II-82FMC Health and Nutrition (US) II-83NovaMatrix ( Norway) II-83GlycoMar Ltd. (UK) II-83Jazz Pharmaceuticals plc ( Ireland) II-84Lonza Group Ltd. ( Switzerland) II-84Marinova Pty Ltd ( Australia) II-84New England Biolabs Inc (US) II-85oceanBASIS GmbH ( Germany) II-85PharmaMar S.A ( Spain) II-85PML Applications Ltd. (UK) II-86Prolume Ltd (US) II-86BioLume®, Inc. (US) II-86Royal DSM N.V ( Netherlands) II-87Sea Run Holdings, Inc. (US) II-87SEPPIC ( France) II-87Biotech Marine ( France) II-88Tequesta BioVentures (US) II-889. GLOBAL MARKET PERSPECTIVE II-89Table 7: World Recent Past, Current & Future Analysis forMarine Biotechnology by Geographic Region – US, Canada, Japan,Europe, Asia-Pacific, and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2013 through 2020 (includes corresponding Graph/Chart) II-89Table 8: World Historic Review for Marine Biotechnology byGeographic Region – US, Canada, Japan, Europe, Asia-Pacific,and Rest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2006 through 2012(includes corresponding Graph/Chart) II-90Table 9: World 15-Year Perspective for Marine Biotechnology byGeographic Region – Percentage Breakdown of Dollar Sales forUS, Canada, Japan, Europe, Asia-Pacific, and Rest of WorldMarkets for Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) II-91Table 10: World Recent Past, Current & Future Analysis forMarine Biotechnology by Product Segment – Biomaterials,Bioactive Substances, and Other Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2013through 2020 (includes corresponding Graph/Chart) II-92Table 11: World Historic Review for Marine Biotechnology byProduct Segment – Biomaterials, Bioactive Substances, andOther Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2006 through 2012 (includescorresponding Graph/Chart) II-93Table 12: World 15-Year Perspective for Marine Biotechnologyby Product Segment – Percentage Breakdown of Dollar Sales forBiomaterials, Bioactive Substances, and Other Markets forYears 2006, 2014 & 2020 (includes corresponding Graph/Chart) II-94Table 13: World Recent Past, Current & Future Analysis forMarine Biotechnology by End-Use Application – IndustrialProducts, Health Care/Biotechnology, Consumer Products, PublicServices & Infrastructure and Other Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2013 through 2020 (includes corresponding Graph/Chart) II-95Table 14: World Historic Review for Marine Biotechnology byEnd-Use Application – Industrial Products, HealthCare/Biotechnology, Consumer Products, Public Services &Infrastructure and Other Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2006 through2012 (includes corresponding Graph/Chart) II-96Table 15: World 15-Year Perspective for Marine Biotechnologyby End-Use Application – Percentage Breakdown of Dollar Salesfor Industrial Products, Health Care/Biotechnology, ConsumerProducts, Public Services & Infrastructure and Other Marketsfor Years 2006, 2014 & 2020 (includes correspondingGraph/Chart) II-97III. MARKET1. THE UNITED STATES III-1A.Market Analysis III-1Overview III-1Aquaculture Biotechnology III-1Policy Framework to Offer Support for Marine Biotechnology III-1Product Introductions/Innovations III-2Strategic Corporate Developments III-2Key Players III-3B.Market Analytics III-6Table 16: US Recent Past, Current & Future Analysis forMarine Biotechnology Analyzed with Annual Sales Figures inUS$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-6Table 17: US Historic Review for Marine BiotechnologyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) III-72. CANADA III-8A.Market Analysis III-8Outlook III-8Strategic Corporate Development III-8B.Market Analytics III-9Table 18: Canadian Recent Past, Current & Future Analysisfor Marine Biotechnology Analyzed with Annual Sales Figuresin US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-9Table 19: Canadian Historic Review for Marine BiotechnologyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) III-103. JAPAN III-11A.Market Analysis III-11Outlook III-11B.Market Analytics III-11Table 20: Japanese Recent Past, Current & Future Analysisfor Marine Biotechnology Analyzed with Annual Sales Figuresin US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-11Table 21: Japanese Historic Review for Marine BiotechnologyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) III-124. EUROPE III-13A.Market Analysis III-13Marine Biotechnology: Promising Opportunities for Europe III-13A Nascent Yet Promising Market III-13Marine and Algae Oils Market in Europe: An Overview III-14Prospects for Blue Technology in Baltic Sea Region III-14A Distinct Identity for Marine Biotechnology: The Way Forward III-15Marine Drug Discovery: Need for Diversifying Research Focus III-15Regulations Governing Marine Biotechnology in Europe III-15A Glance at Key Documents & Events Focused on MarineBiotechnology III-16Initiatives for Marine Biotechnology Growth III-17The European Commission Policies on Blue Technology (Marineand Freshwater Biotechnology) III-18Horizon 2020: Aiming for Faster Marketability of Innovations III-19ERA-NET III-19Focus on Select Regional Markets III-19Belgium III-19Denmark III-20Germany III-20North Germany Focuses on Maritime Resources III-20Ireland III-20Norway III-21Overview III-21Norway Leads in Bioprospecting Arctic Genetic Resources inNordic Countries III-21Market Participants III-22Industrial Applications III-22Pharmaceuticals III-22Norwegian Marine Biotechnology Companies III-22Iceland III-24Spain III-24The United Kingdom III-24Overview III-24Role of Marine Algal Biomass in Energy Sector in UK III-25Product Innovations/Introductions III-25Strategic Corporate Developments III-26Key Players III-28B.Market Analytics III-32Table 22: European Recent Past, Current & Future Analysisfor Marine Biotechnology Analyzed with Annual Sales Figuresin US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-32Table 23: European Historic Review for Marine BiotechnologyAnalyzed with Annual Sales Figures in US$ Million for Years2006 through 2012 (includes corresponding Graph/Chart) III-335. ASIA-PACIFIC III-34A.Market Analysis III-34Outlook III-34Australia III-34China III-34India III-35Marine Environment Offers Abundant Opportunities for R&DInitiatives III-35Biotechnology Market in India on a Growth Trajectory III-35Seaweed: A Lucrative Marine Product III-36Government Initiatives III-36New Zealand III-37South Korea III-37Strategic Corporate Developments III-37Marinova Pty Ltd ( Australia) – A Key Player III-38B.Market Analytics III-39Table 24: Asia-Pacific Recent Past, Current & FutureAnalysis for Marine Biotechnology Analyzed with Annual SalesFigures in US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-39Table 25: Asia-Pacific Historic Review for MarineBiotechnology Analyzed with Annual Sales Figures in US$Million for Years 2006 through 2012 (includes correspondingGraph/Chart) III-406. REST OF WORLD III-41A.Market Analysis III-41Outlook III-41Latin America III-41Brazil III-41B.Market Analytics III-42Table 26: Rest of World Recent Past, Current & FutureAnalysis for Marine Biotechnology Analyzed with Annual SalesFigures in US$ Million for Years 2013 through 2020 (includescorresponding Graph/Chart) III-42Table 27: Rest of World Historic Review for MarineBiotechnology Analyzed with Annual Sales Figures in US$Million for Years 2006 through 2012 (includes correspondingGraph/Chart) III-43IV. COMPETITIVE LANDSCAPETotal Companies Profiled: 84 (including Divisions/Subsidiaries – 89)The United States (25)Canada (1)Japan (2)Europe (44)- France (4)- Germany (4)- The United Kingdom (4)- Spain (2)- Rest of Europe (30)Asia-Pacific (Excluding Japan) (15)Latin America (1)Middle East (1)Read the full report: http://www.reportlinker.com/p080467-summary/view-report.htmlAbout ReportlinkerReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need – instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001
SOURCE Reportlinker

News Reporter